• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道细菌是胃癌的潜在生物标志物和治疗靶点。

Intestinal bacteria are potential biomarkers and therapeutic targets for gastric cancer.

机构信息

School of Basic Medical Science, Cheeloo College of Medicine, Shandong University, Jinan & Shenzhen Hospital, Cancer Hospital of the Chinese Academy of Medical Sciences, Shenzhen, China.

Cancer Therapy and Research Center, Shandong Provincial Hospital, Jinan, Shandong, 250021, China.

出版信息

Microb Pathog. 2021 Feb;151:104747. doi: 10.1016/j.micpath.2021.104747. Epub 2021 Jan 21.

DOI:10.1016/j.micpath.2021.104747
PMID:33484807
Abstract

The diagnostic and therapeutic role of intestinal microbiota in gastric carcinogenesis remains unclear. In this study, feces from gastric cancer patients and healthy people were sequenced for microbiota analysis, and the correlation between fecal bacteria and the occurrence of gastric cancer was explored. The β-diversity results showed that microbial compositions varied between gastric cancer patients and healthy people. Interestingly, the dissection of microbial structure revealed that all facultative anaerobic genera with relatively high abundances expanded significantly in gastric cancer patients. The succeeding correlation analysis demonstrated a distorted interaction of intestinal bacteria in gastric cancer. The application of some differential bacteria, Desulfovibrio, Escherichia, Faecalibacterium or Oscillospira, as biomarkers to predict gastric cancer could all reach an accuracy of 0.900 or above. The shift in Desulfovibrio was specifically verified by qPCR in newly collected fecal samples, and the patients with stage IV gastric cancer were identified to have significantly more Desulfovibrio than those with stage I, II and III gastric cancer. The possible role of Desulfovibrio in gastric cancer was assessed with HS-treated HT-29 cells, and the results showed that HS induced NO, IL-1β and IL-18 production, which is important for inflammation promotion and can be delivered through the bloodstream. This study suggests a correlation of intestinal microbiota and the development of gastric cancer.

摘要

肠道微生物群在胃癌发生中的诊断和治疗作用尚不清楚。在这项研究中,对胃癌患者和健康人的粪便进行了微生物组分析,探讨了粪便细菌与胃癌发生的相关性。β多样性结果表明,胃癌患者和健康人群的微生物组成存在差异。有趣的是,微生物结构的剖析表明,所有丰度较高的兼性厌氧属在胃癌患者中均显著扩张。随后的相关性分析表明,胃癌患者的肠道细菌相互作用发生了扭曲。一些差异细菌,如脱硫弧菌、大肠杆菌、粪杆菌或颤螺旋菌,作为预测胃癌的生物标志物,其准确性均达到 0.900 或以上。通过对新收集的粪便样本进行 qPCR 验证,发现Ⅳ期胃癌患者的脱硫弧菌数量明显多于Ⅰ、Ⅱ和Ⅲ期胃癌患者。通过 HS 处理的 HT-29 细胞评估脱硫弧菌在胃癌中的可能作用,结果表明 HS 诱导了 NO、IL-1β和 IL-18 的产生,这对炎症的促进很重要,并且可以通过血液传递。本研究提示肠道微生物群与胃癌的发展存在相关性。

相似文献

1
Intestinal bacteria are potential biomarkers and therapeutic targets for gastric cancer.肠道细菌是胃癌的潜在生物标志物和治疗靶点。
Microb Pathog. 2021 Feb;151:104747. doi: 10.1016/j.micpath.2021.104747. Epub 2021 Jan 21.
2
Intestinal Microbiota Is Altered in Patients with Gastric Cancer from Shanxi Province, China.中国山西胃癌患者的肠道微生物群发生改变。
Dig Dis Sci. 2019 May;64(5):1193-1203. doi: 10.1007/s10620-018-5411-y. Epub 2018 Dec 7.
3
[Gut Microbiome Differences between Gastrointestinal Cancer Patients and Healthy People].[胃肠道癌症患者与健康人群的肠道微生物组差异]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019 Oct 30;41(5):636-645. doi: 10.3881/j.issn.1000-503X.11372.
4
Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection.治疗前肠道微生物群可预测化疗相关的血流感染。
Genome Med. 2016 Apr 28;8(1):49. doi: 10.1186/s13073-016-0301-4.
5
Gut microbiome analysis as a predictive marker for the gastric cancer patients.肠道微生物群分析作为胃癌患者的预测标志物。
Appl Microbiol Biotechnol. 2021 Jan;105(2):803-814. doi: 10.1007/s00253-020-11043-7. Epub 2021 Jan 6.
6
Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease.肠道微生物群的改变及其与慢性肾脏病中炎症因子的相关性。
Front Cell Infect Microbiol. 2019 Jun 12;9:206. doi: 10.3389/fcimb.2019.00206. eCollection 2019.
7
Fecal Microbiota Taxonomic Shifts in Chinese Multiple Myeloma Patients Analyzed by Quantitative Polimerase Chain Reaction (QPCR) and 16S rRNA High-Throughput Sequencing.基于定量聚合酶链反应(QPCR)和 16S rRNA 高通量测序分析中国多发性骨髓瘤患者粪便微生物分类群变化。
Med Sci Monit. 2019 Nov 3;25:8269-8280. doi: 10.12659/MSM.919988.
8
Enteric Delivery of Regenerating Family Member 3 alpha Alters the Intestinal Microbiota and Controls Inflammation in Mice With Colitis.肠内递送再生家庭成员 3α可改变结肠炎小鼠的肠道微生物群并控制炎症。
Gastroenterology. 2018 Mar;154(4):1009-1023.e14. doi: 10.1053/j.gastro.2017.11.003. Epub 2017 Nov 11.
9
Predominantly Antibiotic-resistant Intestinal Microbiome Persists in Patients With Pouchitis Who Respond to Antibiotic Therapy.主要对抗生素耐药的肠道微生物组在对抗生素治疗有反应的 pouchitis 患者中持续存在。
Gastroenterology. 2020 Feb;158(3):610-624.e13. doi: 10.1053/j.gastro.2019.10.001. Epub 2019 Oct 9.
10
Analysis of Transcriptionally Active Bacteria Throughout the Gastrointestinal Tract of Healthy Individuals.健康个体整个胃肠道中具有转录活性的细菌分析。
Gastroenterology. 2019 Oct;157(4):1081-1092.e3. doi: 10.1053/j.gastro.2019.05.068. Epub 2019 Jun 5.

引用本文的文献

1
Gut microbiome in gastrointestinal neoplasms: from mechanisms to precision therapeutic strategies.胃肠道肿瘤中的肠道微生物群:从机制到精准治疗策略
Gut Pathog. 2025 Jul 30;17(1):57. doi: 10.1186/s13099-025-00734-z.
2
The Role of Beneficial Microbiota in COVID-19: Insights from Key Bacterial Genera.有益微生物群在2019冠状病毒病中的作用:关键细菌属的见解
Microorganisms. 2025 Apr 29;13(5):1029. doi: 10.3390/microorganisms13051029.
3
The gastric microbiome altered by A4GNT deficiency in mice.小鼠中A4GNT缺乏改变的胃部微生物群。
Front Microbiol. 2025 Feb 12;16:1541800. doi: 10.3389/fmicb.2025.1541800. eCollection 2025.
4
Advances in 16S rRNA-Based Microbial Biomarkers for Gastric Cancer Diagnosis and Prognosis.基于16S rRNA的胃癌诊断与预后微生物生物标志物研究进展
Microb Biotechnol. 2025 Feb;18(2):e70115. doi: 10.1111/1751-7915.70115.
5
Exploring changes in metabolites and fecal microbiota of advanced gastric cancer based on plasma metabolomics and 16S rDNA sequencing.基于血浆代谢组学和16S rDNA测序探索晚期胃癌患者代谢物和粪便微生物群的变化
Heliyon. 2025 Jan 6;11(2):e41715. doi: 10.1016/j.heliyon.2025.e41715. eCollection 2025 Jan 30.
6
Unravelling the prognostic and operative role of intratumoural microbiota in non-small cell lung cancer: Insights from 16S rRNA and RNA sequencing.揭示肿瘤内微生物群在非小细胞肺癌中的预后和手术作用:来自16S rRNA和RNA测序的见解
Clin Transl Med. 2025 Jan;15(1):e70156. doi: 10.1002/ctm2.70156.
7
Oral microbiome test as an alternative diagnostic tool for gastric alterations: A prospective, bicentric cross-sectional study.口腔微生物群检测作为胃部病变的替代诊断工具:一项前瞻性、双中心横断面研究。
PLoS One. 2024 Dec 2;19(12):e0314660. doi: 10.1371/journal.pone.0314660. eCollection 2024.
8
From pathogenesis to treatment: the impact of bacteria on cancer.从发病机制到治疗:细菌对癌症的影响
Front Microbiol. 2024 Sep 18;15:1462749. doi: 10.3389/fmicb.2024.1462749. eCollection 2024.
9
Intratumoral and fecal microbiota reveals microbial markers associated with gastric carcinogenesis.肿瘤内和粪便微生物群揭示了与胃癌发生相关的微生物标志物。
Front Cell Infect Microbiol. 2024 Sep 17;14:1397466. doi: 10.3389/fcimb.2024.1397466. eCollection 2024.
10
Gastric Cancer, Immunotherapy, and Nutrition: The Role of Microbiota.胃癌、免疫疗法与营养:微生物群的作用
Pathogens. 2024 Apr 26;13(5):357. doi: 10.3390/pathogens13050357.